Reducing Health Problems Associated With Injection Drug Use
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to develop and test an intervention to reduce bacterial and viral infections among injection drug users.
Condition | Intervention |
---|---|
Intravenous Drug Abuse HIV Infections |
Behavioral: Skin and Needle Hygiene Intervention Other: No intervention - assessment-only condition |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
Official Title: | Reduction of Medical Complications Associated With Injection Drug Use |
- Reduction in self-reported high-risk injection practices for bacterial infections (as measured through the Bacterial Infections Risk Scale for Injectors) [ Time Frame: 1 month ] [ Designated as safety issue: No ]
- Reduction in self-reported high-risk injection practices for bacterial infections (as measured through the Bacterial Infections Risk Scale for Injectors) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Reduction in self-reported high-risk injection practices for HIV/HCV viral infections (as measured through the Risk Assessment Battery) [ Time Frame: 1 month ] [ Designated as safety issue: No ]
- Reduction in self-reported high-risk injection practices for HIV/HCV viral infections (as measured through the Risk Assessment Battery) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Improvement in skin and needle cleaning behavioral skills (as measured through Behavioral Skill Demonstration of Hand/Skin and Needle Cleaning) [ Time Frame: 1 month ] [ Designated as safety issue: No ]
- Increase in skin cleaning prior to injection and decrease in subcutaneous/intramuscular injection, as measured through Timeline Followback (TLFB) recall. [ Time Frame: 1 month ] [ Designated as safety issue: No ]
- Improvement in skin and needle cleaning behavioral skills (as measured through Behavioral Skill Demonstration of Hand/Skin and Needle Cleaning) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Increase in skin cleaning prior to injection and decrease in subcutaneous/intramuscular injection, as measured through Timeline Followback (TLFB) recall. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Enrollment: | 87 |
Study Start Date: | June 2009 |
Study Completion Date: | May 2011 |
Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Experimental: Skin and Needle Hygiene Intervention |
Behavioral: Skin and Needle Hygiene Intervention
Intervention incorporates psychoeducation, correction of false beliefs, counseling to counteract barriers to hygienic practices, motivational enhancement, and behavioral skills training in hygiene practices
|
Experimental: Assessment-Only Condition |
Other: No intervention - assessment-only condition
No intervention is assigned in this condition
|
Detailed Description:
Injection drug use (IDU) is a major public health problem that is associated with a host of medical complications, including blood-borne viral disease (e.g., HIV, Hepatitis C) and bacterial infections (e.g., skin abscesses, endocarditis), that often result from high-risk drug injection practices. There are no current interventions designed to reduce bacterial infections among IDUs, despite high rates of infection.
The objective of this study is to develop and test the efficacy of a skin and needle hygiene intervention for IDUs to reduce practices associated with bacterial and viral infections. In the first phase of the study, focus group interviews were conducted to determine key areas of emphasis for an intervention with this population. An initial intervention was developed, pilot tested, and refined. The final 2-session intervention combines psychoeducation, skill-building, and motivational interviewing.
Following refinement of the intervention, a small randomized controlled trial (n = 60; 30 in each group) to examine the efficacy of the intervention compared to an assessment-only condition will be conducted. The goals of this two-year study are to: 1) reduce high-risk injection practices among active IDUs that lead to bacterial and viral infections, 2) improve skin and needle cleaning behavioral skills, and 3) increase skin cleaning prior to injection and reduce subcutaneous/intramuscular injection.
In addition to examining these goals over a six-month period, the acceptability and feasibility of the intervention will be examined.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18 years of age or older
- injection of heroin on at least three different days in the last week
- injection of heroin for at least three months
- visible track marks/puncture wounds from needles
- positive urine screen for heroin
Exclusion Criteria:
- currently exhibiting active psychotic symptoms
- cannot complete study assessments or the intervention
- cannot provide informed consent
- unable to provide names and contact information for at least two verifiable locator persons who will know where to find client
- plans to relocate from area or be jail over next six months
- have been in a Project Safe study in the last year
- report being pregnant or attempting to become pregnant
United States, Colorado | |
Project Safe, University of Colorado | |
Denver, Colorado, United States, 80506 |
Principal Investigator: | Kristina T Phillips, Ph.D. | University of Northern Colorado |
No publications provided
Responsible Party: | Kristina Phillips, Associate Professor, University of Northern Colorado |
ClinicalTrials.gov Identifier: | NCT01128920 History of Changes |
Other Study ID Numbers: | DA026773-01 |
Study First Received: | May 19, 2010 |
Last Updated: | December 30, 2011 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Northern Colorado:
bacterial infections skin infections HIV Hepatitis C risk reduction intervention |
Additional relevant MeSH terms:
HIV Infections Acquired Immunodeficiency Syndrome Substance-Related Disorders Substance Abuse, Intravenous Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases Mental Disorders |
ClinicalTrials.gov processed this record on March 03, 2013